These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2999821)

  • 1. Role of complement anaphylatoxins in neutrophil arachidonic acid metabolism.
    Clancy RM; Hugli TE
    Prog Clin Biol Res; 1985; 199():173-84. PubMed ID: 2999821
    [No Abstract]   [Full Text] [Related]  

  • 2. Arachidonic acid, leukotriene B4, and neutrophil activation.
    Naccache PH; Sha'afi RI
    Ann N Y Acad Sci; 1983; 414():125-39. PubMed ID: 6322649
    [No Abstract]   [Full Text] [Related]  

  • 3. C5a: a mediator of chemotaxis and cellular release reactions.
    Gerard C; Hugli TE
    Kroc Found Ser; 1981; 14():147-60. PubMed ID: 6975805
    [No Abstract]   [Full Text] [Related]  

  • 4. Contribution of complement factors and reaction pathways to inflammation.
    Bitter-Suermann D
    Agents Actions Suppl; 1982; 11():159-78. PubMed ID: 6758550
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of low dose methotrexate on neutrophil chemotaxis induced by leukotriene B4 and complement C5a.
    Suarez CR; Pickett WC; Bell DH; McClintock DK; Oronsky AL; Kerwar SS
    J Rheumatol; 1987 Feb; 14(1):9-11. PubMed ID: 3033240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylatoxins: possible roles in disease.
    Vogt W
    Complement; 1986; 3(3):177-88. PubMed ID: 3026724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3a-induced lysosomal enzyme secretion from human neutrophils: lack of inhibition by f met-leu-phe antagonists and inhibition by arachidonic acid antagonists.
    Showell HJ; Glovsky MM; Ward PA
    Int Arch Allergy Appl Immunol; 1982; 67(3):227-32. PubMed ID: 6800960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mediators released by complement-derived peptides.
    Bult H; Herman AG
    Agents Actions; 1983 Aug; 13(5-6):405-14. PubMed ID: 6416038
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic defense mechanism of complement-derived inflammatory chemical mediators].
    Yamamoto T; Kambara T
    Nihon Rinsho; 1988 Sep; 46(9):1974-80. PubMed ID: 3266512
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement as a mediator of granulocyte adherence and margination: studies based on the acute neutropenia of filtration leukapheresis.
    Fehr J
    Prog Clin Biol Res; 1977; 13():243-58. PubMed ID: 400757
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the complement anaphylatoxins in inflammation and hypersensitivity reactions in the lung.
    Stimler-Gerard NP
    Surv Synth Pathol Res; 1985; 4(5-6):423-42. PubMed ID: 3879815
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation.
    O'Flaherty JT; Hammett MJ; Shewmake TB; Wykle RL; Love SH; McCall CE; Thomas MJ
    Biochem Biophys Res Commun; 1981 Nov; 103(2):552-8. PubMed ID: 6277309
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-specific mechanisms for the responses of human leukocytes to leukotrienes.
    Goetzl EJ; Sherman JW; Ratnoff WD; Harvey JP; Eriksson E; Seaman WE; Baud L; Koo CH
    Ann N Y Acad Sci; 1988; 524():345-55. PubMed ID: 2837968
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of C3a in pulmonary alveoli following trauma.
    Obertacke U; Joka T; Zilow G; Kirschfink M; Schmit-Neuerburg KP
    Prog Clin Biol Res; 1989; 308():43-9. PubMed ID: 2789395
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukotrienes and related compounds.
    Samuelsson B
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():1-9. PubMed ID: 3004127
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of arachidonate metabolism by endotoxin and the terminal complement complex C5b-8.
    Suttorp N; Seeger W; Neuhof H
    Prog Clin Biol Res; 1989; 301():217-21. PubMed ID: 2552460
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neutrophil chemotaxis and its role in the pathogenesis of dermatoses].
    Skripkin IuK; Lezvinskaia EM
    Vestn Dermatol Venerol; 1986; (6):31-7. PubMed ID: 3019036
    [No Abstract]   [Full Text] [Related]  

  • 19. Microvascular effects of anaphylatoxins C3a and C5a.
    Björk J; Hugli TE; Smedegård G
    J Immunol; 1985 Feb; 134(2):1115-9. PubMed ID: 3871207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation products and monocyte migratory function in trauma.
    Antrum RM; Solomkin JS
    Curr Surg; 1985; 42(4):301-3. PubMed ID: 3875452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.